Reversal of EGFR inhibitors’ resistance by co-delivering EGFR and integrin αvβ3 inhibitors with nanoparticles in non-small cell lung cancer

Purpose: Tumor cells, with drug resistance, are associated with failed treatment and poor prognosis. Our aim was to explore potential strategy to overcome the epidermal growth factor receptor (EGFR) inhibitors resistance in non-small cell lung cancer (NSCLC). Materials and methods: Flow cytometry wa...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Fei, Wang, Yanzhong, Cai, Wanru, Li, Minjing, Dong, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712436/
https://www.ncbi.nlm.nih.gov/pubmed/31316001
http://dx.doi.org/10.1042/BSR20181259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712436/
https://www.ncbi.nlm.nih.gov/pubmed/31316001
http://dx.doi.org/10.1042/BSR20181259

Ejemplares similares